Ekso Bionics Holdings Inc (NAS:EKSO)
$ 0.61 0.005 (0.83%) Market Cap: 13.31 Mil Enterprise Value: 11.08 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 60/100

Q2 2022 Ekso Bionics Holdings Inc Earnings Call Transcript

Jul 28, 2022 / 08:30PM GMT
Release Date Price: $1.73 (+1.17%)
Operator

Hello, and welcome to the Ekso Bionics Q2 2022 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to turn the call over to David Carey. Please go ahead.

David Carey
Lazar Partners Ltd. - MD of IR

Thank you, operator, and thank you all for participating in today's call. Joining me from Ekso Bionics are Steven Sherman, Chairman and Chief Executive Officer; Scott Davis, President and Chief Operating Officer; and Jerome Wong, Interim Chief Financial Officer. Earlier today, Ekso Bionics released financial results for the second quarter of 2022. A copy of the press release is available on the company's website.

Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that are not statements of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot